Rchr
J-GLOBAL ID:200901059380416479   Update date: Apr. 16, 2020

Umehara Fujio

ウメハラ フジオ | Umehara Fujio
Affiliation and department:
Research field  (1): Neurology
Research keywords  (2): 神経内科学 ,  Neurology
Research theme for competitive and other funds  (4):
  • 神経の発生と再生に関する研究
  • HTLV-1 associated myelopathyに関する研究
  • Study on embryology and regereration in nervous system
  • Study on HTLV-1-associated myelopathy
MISC (21):
  • Ikegami M, Umehara F, Ikegami N, Maekawa R, Osame M. Selective Matrix Metalloproteinase Inhibitor, N-Biphenyl Sulfonyl Phenylalanine Hydroxamic Acid, Inhibits the Migration of CD4+ T Lymphocytes in Patients with HTLV-I-Associated Myelopathy. J Neuroimmunol. 2002. 127: 134-8
  • Umehara F, Tate G, Itoh K, Osame M. Minifascicular Neuropathy: a New Concept of the Human Disease Caused by Desert Hedgehog Gene Mutation. Cell Mol Biol. 2002. 48: 187-9
  • Sugie K, Futamura N, Suzumura A, Tate G, Umehara F. Hereditary Motor and Sensory Neuropathy with Minifascicle Formation in anPatient with 46XY Pure Gonadal Dysgenesis: a New Clinical Entity. Ann Neurol. 2002. 51: 385-8
  • Ikegami M, Umehara F, Ikegami N, Maekawa R, Osame M. Selective Matrix Metalloproteinase Inhibitor, N-Biphenyl Sulfonyl Phenylalanine Hydroxamic Acid, Inhibits the Migration of CD4+ T Lymphocytes in Patients with HTLV-I-Associated Myelopathy. J Neuroimmunol. 2002. 127: 134-8
  • Umehara F, Tate G, Itoh K, Osame M. Minifascicular Neuropathy: a New Concept of the Human Disease Caused by Desert Hedgehog Gene Mutation. Cell Mol Biol. 2002. 48: 187-9
more...
Education (2):
  • - 1981 Kagoshima University Faculty of Medicine
  • - 1981 Kagoshima University Faculty of Medicine
Professional career (1):
  • (BLANK)
Work history (1):
  • 1997 - 2002 Kagoshima University Faculty of Medicine
Committee career (1):
  • 1998 - 日本神経学会 評議員
Association Membership(s) (5):
日本神経治療学会 ,  日本神経免疫学会 ,  日本神経病理学会 ,  日本内科学会 ,  日本神経学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page